OTCMKTS:RKAGY RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Stock Price, News & Analysis $7.85 0.00 (0.00%) As of 05/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendShort InterestBuy This Stock About RHÖN-KLINIKUM Aktiengesellschaft Stock (OTCMKTS:RKAGY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RKAGY alerts:Sign Up Key Stats Today's Range$7.85▼$7.8550-Day Range$7.40▼$9.0752-Week Range$7.40▼$9.07VolumeN/AAverage Volume287 shsMarket CapitalizationN/AP/E Ratio1.74Dividend Yield1.05%Price TargetN/AConsensus RatingN/A Company OverviewRHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.Read More… RHÖN-KLINIKUM Aktiengesellschaft Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreRKAGY MarketRank™: RHÖN-KLINIKUM Aktiengesellschaft scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for RHÖN-KLINIKUM Aktiengesellschaft. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.79.Price to Earnings Ratio vs. SectorThe P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.74, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.72.Read more about RHÖN-KLINIKUM Aktiengesellschaft's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverRHÖN-KLINIKUM Aktiengesellschaft has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipRHÖN-KLINIKUM Aktiengesellschaft is a leading dividend payer. It pays a dividend yield of 5.34%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthRHÖN-KLINIKUM Aktiengesellschaft does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about RHÖN-KLINIKUM Aktiengesellschaft's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverRHÖN-KLINIKUM Aktiengesellschaft has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for RKAGY on MarketBeat in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, RHÖN-KLINIKUM Aktiengesellschaft insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.17% of the stock of RHÖN-KLINIKUM Aktiengesellschaft is held by institutions.Read more about RHÖN-KLINIKUM Aktiengesellschaft's insider trading history. Receive RKAGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address RKAGY Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com RKAGY Stock Analysis - Frequently Asked Questions How have RKAGY shares performed this year? RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $6.05 on January 1st, 2025. Since then, RKAGY stock has increased by 29.8% and is now trading at $7.85. View the best growth stocks for 2025 here. How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft? Shares of RKAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/23/2025Next Earnings (Estimated)8/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:RKAGY CIKN/A Webwww.rhoen-klinikum-ag.com Phone499771650FaxN/AEmployees18,282Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1.74 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:RKAGY) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RHÖN-KLINIKUM Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share RHÖN-KLINIKUM Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.